SARM1 is a key regulator of axonal degeneration. However, SARM1 mechanism of action is not clear. In this issue of Neuron, Essuman et al. (2017) reveal an intrinsic NADase activity in the SARM1-TIR domain that is required for axonal degeneration.
Axon degeneration is a process of axonal self-destruction that occurs during normal development and in response to insult or disease (Neukomm and Freeman, 2014; Schuldiner and Yaron, 2015) . One of the most characterized forms is Wallerian degeneration, which occurs after axotomy. Wallerian degeneration was described as a passive process by Augustus Volney Waller in 1850, wherein the axons that are disconnected from the cell body fragment due to wasting away of nutrients and energy sources. However, the discovery of a mouse strain carrying the spontaneous gain-of-function mutation Wallerian degeneration slow (Wld s ) has radically challenged this dogma of passive axonal death (Neukomm and Freeman, 2014 (Osterloh et al., 2012) . Moreover, artificial activation of SARM1 in intact axons caused degeneration (Gerdts et al., 2016) . These findings suggested that SARM1 is both required and sufficient for axonal degeneration. Upon injury, SARM1 is stimulated and promotes rapid loss of NAD + , which in turn leads to axonal degeneration both in neuronal cultures and in vivo. SARM1 is mainly associated with the outer mitochondrial membrane and consists of several domains: MLS, mitochondrial localization signal; ARM, armadillo/HEAT motifs; SAM, sterile alpha motif; and TIR, Toll-interleukin 1 receptor. The TIR domain of SARM1 (SARM1-TIR) is required for its activity and can trigger axonal degeneration by forced dimerization and by injury-independent NAD + loss (Gerdts et al., 2015) . However, TIR domains are not known to have any intrinsic catalytic activity and serve mainly as scaffold proteins for Toll-like receptor (TLR) signaling. Hence, the mechanism by which the SARM1-TIR domain promotes axonal degeneration has remained elusive until the unexpected findings of Essuman et al. (2017) 
(this issue of Neuron).
In this study, Milbrandt and colleagues aimed to discover the enzyme that mediates SARM1-TIR-dependent depletion of NAD + levels following axonal injury (Essuman et al., 2017) . Starting from analysis of a purified SARM1-TIR domain complex expressed in mammalian cells, they found that this purified complex indeed contained NAD + -degrading activity in vitro. Surprisingly, proteins previously described to degrade NAD + , such as the poly(ADP-ribose) polymerase family (PARPs), Sirtuins, ADP ribosyltransferases (ARTs), and CD38, were not detected in highly sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis of the SARM1-TIR complex.
These unexpected results suggested that the SARM1-TIR domain itself might have intrinsic NADase activity. Essuman et al. (2017) implemented two main strategies to test this possibility, first expressing the human SARM1-TIR (hSARM1-TIR) domain in E. coli with the assumption that any bacterial NADase would not associate with the human SARM1-TIR. In the second approach, they synthetized hSARM1-TIR domain in a cell-free protein expression system. In both systems, purified hSARM1-TIR demonstrated the capacity to exhaust NAD + levels. Furthermore, endogenous Essuman et al. (2017) found that hSARM1-TIR domain serves as a cyclase and glycohydrolase, cleaving NAD + mainly into nicotinamide (Nam) and ADPR, as well as cADPR to a lesser extent. Among these cleavage products, Nam was found to regulate SARM1-TIR enzymatic activity via negative feedback, highlighting the potential for development of axon degeneration-preventing therapeutic agents by inhibition of SARM1-TIR domain activity.
Structural insights into the SARM1-TIR domain enzymatic activity were obtained using a homology-based prediction algorithm to find proteins with similar domains. In addition to the expected TIR domains, Essuman et al. (2017) also identified several nucleotide hydrolase/transferase enzymes. The critical catalytic residues are already known for some of these, and data from hydrolase and a transferase were then used to construct a structural model of SARM1-TIR. The computational analysis predicted that glutamic acid 642 (E642) in the SARM1-TIR domain might be a key residue for the enzymatic reaction. Indeed, upon mutation of this residue to alanine, the purified mutant protein lost its NAD + cleavage activity.
Finally, Essuman et al. (2017) tested the importance of E642 for SARM1 prodegenerative activity using a complementation approach in SARM1 knockout neurons. In agreement with the previous results, while the introduction of wild-type SARM1 resulted in axonal NAD + depletion and axon degeneration following axotomy, axons that expressed the enzymatically inactive SARM1-E642A remained intact.
Overall, Essuman et al. (2017) reveal, for the first time, an enzymatic activity of a TIR domain that is required for axonal degeneration (see Figure 1) . This raises the question of whether other TIR domains may serve not only as scaffolds, but also as enzymes that regulate different cellular responses in different biological systems. In this regard, it is noteworthy that forced dimerization of TLR4 or MYD88 TIR domains did not result in axonal degeneration or NAD + depletion (Gerdts et al., 2015) . Therefore, the NADase activity of SARM1 may be unique. High-resolution structures of the SARM1-TIR domain with NAD + or its analogs will provide insights on this distinct activity and its putative structural similarity to nucleotide hydrolases.
While the discovery that SARM1 contains intrinsic NADase activity is a major step in our understanding of Wallerian degeneration, there are still many missing pieces in the puzzle. For example, the upstream signal that activates SARM1 in response to different insults is still not known. In addition, the connections between many other degeneration regulators and SARM1, and how NMNAT2 counters its prodegenerative activity, are not well understood (Gerdts et al., 2016) . Finally, the physiological function of SARM1 in the nervous system is still enigmatic. Co-ablation of SARM1 in the NMNAT2 knockout mouse completely rescues both axonal growth and lethality phenotypes, suggesting that a balance between these two proteins is important for wiring of the nervous system (Gilley et al., 2015) . Studies in C. elegans have shown that TIR-1, the SARM1 ortholog, is required for nonapoptotic cell death and asymmetric patterns of odorant receptor expression (Neukomm and Freeman, 2014) . Based on the mutational analysis that was done by Essuman et al. (2017) , it will be intriguing to test whether these biological activities of TIR-1 are mediated by the NADase activity as well. Recent genetic studies provided strong evidence that SARM1 is required for vincristine-induced axonal neuropathy and that loss of SARM1 results in improved functional outcome after traumatic brain injury (Geisler et al., 2016; Henninger et al., 2016) . However, inhibition of a putative scaffold protein by small molecules is highly challenging. The current discovery that SARM1-TIR domain has an enzymatic activity, which is critical for axonal degeneration, makes it an attractive target for the development of effective anti-degenerative drugs for these conditions and other SARM1-dependent neurodegenerative diseases (Hill et al., 2016) . (2017) show that a2d4 subunits link calcium channels to a trans-synaptic complex with glutamate receptors at the visual system's first synapse.
If at night you worry about the state of this planet and look through a telescope for alternative destinations, you need the optical elements of your telescope and eye to be aligned. Then, as a few photons hit your retina, rod photoreceptors (rods for short) initiate signals that need to propagate across many synapses before you can identify the celestial light source. Like the propagation of photons through your telescope and eye, the propagation of signals across synapses requires alignment, between presynaptic sites of transmitter release and postsynaptic transmitter receptors. The molecular mechanisms that align synapses are mostly unknown. In this issue of Neuron, Wang et al. (2017) show that the auxiliary calcium channel subunit a2d4 plays a critical role in aligning synapses between rods and rod bipolar cells (RBCs) .
The synapses between rods and RBCs are spatially and molecularly complex (Figure 1 ). Rod axons end in a single spherule with a basal invagination in the outer plexiform layer. At the roof of each invagination, glutamate-filled vesicles are tethered to an electron-dense ribbon, and voltage-gated calcium channels are enriched in an active zone of the plasma membrane to which the ribbon is anchored. Calcium influx at the active zone triggers vesicle fusion and the release of glutamate into the synaptic cleft. RBC dendrites enter spherule invaginations, and metabotropic glutamate receptors (mGluR6) cluster at dendritic tips opposite presynaptic active zones. Signals from mGluR6 are relayed via second messengers to a cation non-selective channel (Trpm1), which depolarizes RBCs in response to light. In addition to RBC dendrites, horizontal cell axons penetrate spherules and provide inhibitory feedback to rods. Whereas many of the proteins involved in preand postsynaptic signaling in rods and RBCs, respectively, have been identified (Hoon et al., 2014) , the mechanisms that align pre-and postsynaptic machineries remain obscure. This disparity is common to our knowledge of synapses across the nervous system.
A couple of years ago, Cao et al. (2015) conducted a proteomic screen for binding partners of mGluR6. The top hit in this screen was the leucine-rich repeat protein ELFN1. Cao et al. (2015) found that ELFN1 was expressed selectively by rods and reached across the synapse to interact with mGluR6 on RBCs. When ELFN1 was deleted (ELFN1 KO mice), synapses between rods and RBCs failed to form or were not maintained. Moreover, RBC dendrites, but not horizontal cell axons, were absent from rod spherule invaginations in ELFN1 KO mice (Cao et al., 2015) . Although this study identified a trans-synaptic complex through which rods and RBCs interact, how presynaptic transmitter release sites are aligned with this complex and thus with postsynaptic receptors remained unclear.
The pore-forming Cav1.4 subunit of voltage-gated calcium channels is required for the structural and functional integrity of the presynaptic release machinery in rods. Mutations in Cav1.4 cause congenital stationary night blindness in people (Strom et al., 1998) , and Cav1.4 KO mice exhibit deficits in signal transmission from rods to RBCs and in the assembly and/or maintenance of presynaptic ribbons (Mansergh et al., 2005) . Cao et al. (2015) found
